MyAverix Finance
F · Healthcare
NUREXONE BIOLOGIC INC. (J90)
Biotechnology
NUREXONE BIOLOGIC INC. (J90) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $34.19M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for J90
NUREXONE BIOLOGIC INC. (J90) — FAQ
What is NUREXONE BIOLOGIC INC.'s market cap?
NUREXONE BIOLOGIC INC. (J90) has a reported market cap of $34.19M (data as of 2026-03-29).
What is J90's P/E ratio?
The price-to-earnings (P/E) ratio for NUREXONE BIOLOGIC INC. (J90) is 18.00 (data as of 2026-03-29).
Does NUREXONE BIOLOGIC INC. pay a dividend?
Dividend yield is not available in the current snapshot for NUREXONE BIOLOGIC INC. (J90). Check the MyAverix Finance app for the latest dividend data.
What sector is NUREXONE BIOLOGIC INC. in?
NUREXONE BIOLOGIC INC. (J90) is classified in the Healthcare sector (Biotechnology industry).
What exchange is J90 listed on?
J90 is listed on F.
What is NUREXONE BIOLOGIC INC.'s net margin?
NUREXONE BIOLOGIC INC. (J90) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.